BCAB BioAtla, Inc.

-

BioAtla Reported Earnings

Thursday, August 13, 2026 · 12:00 AM ET

BioAtla (BCAB) reported earnings of $0.14 per share on revenue of $6.50 million for the . .

ioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services.

Earnings Whisper Grade
Power Rating
Reported Earnings
$0.14
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth145.2 %
Reported Revenue
$6.50M
Revenue Estimate
Revenue Surprise
Revenue Growth